Results 11 to 20 of about 7,493 (166)
Research progress on phosphodiesterase 4 inhibitors in the treatment of palmoplantar pustulosis
Palmoplantar pustulosis (PPP) is a chronic recurrent inflammatory skin disease. Existing therapeutic methods cannot meet the demand by patients. Phosphodiesterase-4 (PDE-4) is a key enzyme involved in the balance of immunocytes.
YAO Xinyi +3 more
doaj +2 more sources
Acute generalized exanthematous pustulosis due to insect bites?
Acute generalized exanthematous pustulosis is a rare severe cutaneous adverse reaction pattern that is mostly caused by the intake of drugs and rarely associated with viral infections, food allergens or toxins.
Yasmeen J Bhat +4 more
doaj +2 more sources
Zmiany krostkowe dłoni i stóp (pustulosis palmoplantaris – PPP) są jednostkąchorobową o nieustalonej pozycji nozologicznej. Część badaczyzalicza je do grupy łuszczycy, inni wskazują na liczne odrębnościi wyodrębniają PPP jako samodzielną jednostkę ...
Magdalena Misiak-Gałązka, Hanna Wolska
doaj +1 more source
In recent years, with the increased usage of tumour necrosis factor (TNF) inhibitors, more side effects have been revealed. Paradoxical psoriasis, including psoriasis vulgaris, palmoplantar pustulosis, scalp psoriasis and their combinations, is a common ...
Ying Wang, Yong Cui, Zhancai Zheng
doaj +2 more sources
Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis
The PSORS1 locus in the major histocompatibility complex region is the major genetic determinant for psoriasis vulgaris. Within the PSORS1 region reside at least three potential candidate genes for psoriasis susceptibility.
Burden, David A. +17 more
core +9 more sources
Summary:. We report a case of a 52-year-old woman who developed acute localized exanthematous pustulosis, a rare drug reaction, after cefazolin administration for a face and neck surgery.
Liliana Fort +3 more
doaj +2 more sources
Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study. [PDF]
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Kern JS +14 more
europepmc +2 more sources
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis : report on five cases [PDF]
Infliximab is a monoclonal antibody directed against TNF-alpha. It has been approved for use in rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriatic arthritis and plaque-type psoriasis.
Krüger, Ullrich +13 more
core +1 more source
Acute generalized exanthematous pustulosis provoked by furosemide [PDF]
Introduction. Acute generalized exanthematous pustulosis (AGEP) is a skin disease characterized by the sudden appearance of generalized pustules, accompanied by elevated body temperature and neutrophilia. Objective.
Aleksandra Wilkowska +4 more
core +1 more source
Yanfeng Zhang,1 Yujia Luo,1 Yachao Ruan,2 Xiang Qian,3 Zhiying Feng1 1Department of Pain Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, People’s Republic of China; 2Department of Radiology ...
Zhang Y, Luo Y, Ruan Y, Qian X, Feng Z
doaj

